https://3eff.com/wp-content/uploads/3eff_logoOK.png00adm1nhttps://3eff.com/wp-content/uploads/3eff_logoOK.pngadm1n2024-11-01 16:24:212025-07-10 14:21:13Budget-Impact Analysis of Encorafenib Plus Binimetinib as a Treatment for Advanced NSCLC With BRAFV600-Mutation in Older Adults From Argentina
